Physician profile
Lisa Ramirez Kroopf
NPI 1487896585
$91,079.36
in general payments reported to CMS, 2019-2025
45 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 79% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,401 · 2020: $14K · 2021: $30K · 2022: $38K · 2023: $2,472 · 2024: $1,811 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,617 · Travel and Lodging: $57.88 · Education: $36.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,616.98 |
| Travel and Lodging | $57.88 |
| Education | $36.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $40,095.59 | 2021-2024 | Mild Device Kit |
| Boston Scientific Corporation | $32,804.98 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, General - Pain Management |
| Abbott Laboratories | $10,281.55 | 2019-2024 | Eterna, Proclaim |
| Nevro Corp. | $1,812.11 | 2019-2023 | Senza |
| Relievant Medsystems, INC. | $1,308.95 | 2022-2023 | Intracept |
| Vertiflex, INC. | $1,132.65 | 2019 | |
| Stimwave Technologies Incorporated | $453.33 | 2019 | |
| Spr Therapeutics, INC | $430.27 | 2023-2025 | Sprint Pns System |
| Abbvie INC. | $283.98 | 2021-2024 | |
| Saluda Medical Americas, INC. | $274.21 | 2023 | Evoke Scs |
| Glaxosmithkline, LLC. | $238.15 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Painteq LLC | $214.69 | 2021-2024 | Painteq |
| Mml US, INC. | $190.89 | 2024-2025 | Reactiv8 |
| Medtronic, INC. | $170.90 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.49 | 2021-2023 | Relistor |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Kroopf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.